UCB Not for Sale as Billionaire Shareholder Awaits Reward

UCB SA’s biggest shareholder says the Belgian drugmaker isn’t for sale, even as analysts say medicines for rheumatoid arthritis and epilepsy make the company an attractive takeover target.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.